Reaction

Lung Hyperinflation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 853 reports · 32 co-occurring drugs

As of the last recalculation, Lung Hyperinflation appears in 853 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 91.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ciclesonide	48	91.1	91.4
Theophylline	31	68.3	68.4
Theophylline Anhydrous	31	63.3	63.4
Fluticasone Furoate And Vilanterol Trifenatate	77	57.3	57.4
Mepolizumab	101	56.1	56.2
Fluticasone Furoate	25	51.8	52.0
Ipratropium Bromide	69	51.3	51.4
Sevoflurane	16	47.9	47.9
Tiotropium Bromide	195	44.7	44.8
Magnesium Sulfate In Water For	21	41.1	41.2
Magnesium Sulfate Heptahydrate	21	40.3	40.4
Salmeterol Xinafoate	14	40.3	40.3
Magnesium Sulfate	21	40.2	40.3
Fluticasone Propionate And Salmeterol Xinafoate	86	38.7	38.8
Tiotropium Bromide Inhalation Spray	17	37.7	37.8
Dutasteride	11	33.4	33.5
Montelukast Sodium	136	32.2	32.3
Budesonide And Formoterol Fumarate Dihydrate	106	30.3	30.3
Moxifloxacin Hydrochloride	22	27.2	27.2
Omalizumab	81	25.5	25.5
Terazosin Hydrochloride	9	24.9	25.0
Umeclidinium	9	24.8	24.8
Albuterol Sulfate	221	24.2	24.2
Azithromycin Dihydrate	45	19.7	19.7
Mometasone Furoate	32	19.4	19.4
Montelukast	61	19.0	19.0
Piperacillin Sodium,Tazobactam Sodium	16	15.0	15.0
Mometasone Furoate And Formoterol Fumarate Dihydrate	7	11.0	11.0
Loratadine And Pseudoephedrine Sulfate	3	9.2	9.2
Umeclidinium Bromide And Vilanterol Trifenatate	6	8.8	8.8
Palivizumab	5	8.0	8.0
Budesonide, Glycopyrrolate, And Formoterol Fumarate	3	7.0	7.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.